公司概覽
業務類別 Medical Devices
業務概覽 Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives roughly 60% of sales outside the United States.
公司地址 100 Abbott Park Road, Abbott Park, IL, USA, 60064-6400
電話號碼 +1 224 667-6100
傳真號碼 --
公司網頁 https://www.abbott.com
員工數量 115000
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Mr. Robert B. Ford Chairman of the Board and Chief Executive Officer 美元 1.50M 20/02/2026
Mr. Daniel Gesua Sive Salvadori Executive Vice President and Group President, Established Pharmaceuticals and Nutritional Products 美元 879.27K 20/02/2026
Mr. Eric Shroff Senior Vice President, Rapid and Molecular Diagnostics -- 20/02/2026
Mr. Christopher J. Scoggins Executive Vice President, Diabetes Care -- 20/02/2026
Ms. Mary K. Moreland Executive Vice President, Human Resources -- 20/02/2026
Ms. Lisa D. Earnhardt Executive Vice President and Group President, Medical Devices 美元 879.27K 20/02/2026
Mr. Philip P. Boudreau Executive Vice President, Finance and Chief Financial Officer 美元 884.04K 20/02/2026
Mr. Louis H. Morrone Executive Vice President, Core Diagnostics -- 20/02/2026
Ms. Elizabeth C. Cushman Executive Vice President, General Counsel and Secretary -- 20/02/2026
Mr. John A. Mccoy, Jr Vice President, Finance, Controller and Principal Accounting Officer -- 20/02/2026
 
董事會成員
董事會 職務 更新日期
Dr. Robert J. Alpern,M.D. Independent Director 20/02/2026
Mr. John G. Stratton Independent Director 20/02/2026
Ms. Nancy Mckinstry Lead Independent Director 20/02/2026
Dr. Sally E. Blount, PhD Independent Director 20/02/2026
Mr. Michael F. Roman Independent Director 20/02/2026
Mr. Robert B. Ford Chairman of the Board and Chief Executive Officer 20/02/2026
Mr. Daniel J. Starks Independent Director 20/02/2026
General Darren W. McDew, U.S.A.F. (Ret.) Independent Director 20/02/2026
Ms. Patricia P. Gonzalez Independent Director 20/02/2026
Ms. Michelle A. Kumbier Independent Director 20/02/2026
Mr. Michael G. O’Grady Independent Director 20/02/2026
Ms. Claire Babineaux-Fontenot Independent Director 20/02/2026
Ms. Nita Ahuja, M.D. Director 20/02/2026
 
所屬ETF (更新日期: 07/03/2026 04:44)
代號 名稱 佔比% 持有日期
GLOFiShares Global Equity Factor ETF0.0002%28/02/2026
MFUSPIMCO RAFI Dyn Multi-Factor US Eq ETF0.0002%26/02/2026
FADFirst Trust Multi Cap Gr AlphaDEX® ETF0.0002%26/02/2026
MMTMState Street® SPDR® S&P® 1500MomtTiltETF0.0001%27/02/2026
PRVSParnassus Value Select ETF0.0001%19/02/2026
KNGZFirstTrust S&P500 DvrsDiv AristocratsETF0.0001%26/02/2026
SPXNProShares S&P 500® ex-Financials0.0001%27/02/2026
SPINState Street® US Equity Premium Inc ETF0.0001%27/02/2026
SPXEProShares S&P 500® ex-Energy0.0001%27/02/2026
BIGYYieldMax Target 12 Big 50 Option Inc ETF0.0001%27/02/2026
OEIOptimized Equity Income ETF0.0001%27/02/2026
XRLVInvesco S&P 500® ex-Rate Snsv LowVol ETF0.0001%18/02/2026
CSMProShares Large Cap Core Plus0.0001%27/02/2026
NDVGNuveen Dividend Growth ETF0.0001%27/02/2026
RSPEInvesco ESG S&P 500 Equal Weight ETF0.0001%27/02/2026
XYLGGlobal X S&P 500® Covered Call & Gr ETF0.0001%27/02/2026
PSTRPeakShares Sector Rotation ETF0.0001%23/02/2026
MAGAPoint Bridge America First ETF0.0001%27/02/2026
SHRYFirst Trust Bloomberg Shld Yld ETF0.0001%26/02/2026
PHDGInvesco S&P 500® Downside Hedged ETF0.0001%27/02/2026
  1    2    3    4    5    6    7    8    9    10    11    12    13   14    15    16    17    18    19    20    21  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.